Publication Name	World Journal of Gastroenterology
Manuscript ID	41459
Country	United States

Received	2018-08-08 07:34
Peer-Review Started	2018-08-08 08:17
First Decision by Editorial Office Director	2018-08-24 10:15
Return for Revision	2018-08-27 06:10
Revised	2018-10-04 05:36
Publication Fee Transferred
Second Decision by Editor	2018-10-15 08:47
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2018-10-15 18:20
Articles in Press	2018-10-15 18:20
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-11-06 03:52
Publish the Manuscript Online	2018-11-07 02:30

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Cohort Study
Article Title	End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients
Manuscript Source	Invited Manuscript
All Author List	Tarek Sawas, Fateh Bazerbachi, Samir Haffar, Won K Cho, Michael Levy, John A Martin, Bret T Petersen, Mark Topazian, Vinay Chandrasekhara and Barham K Abu Dayyeh
ORCID	Author(s) ORCID Number Tarek Sawas http://orcid.org/0000-0002-0025-9827 Fateh Bazerbachi http://orcid.org/0000-0003-4599-2042 Samir Haffar http://orcid.org/0000-0002-4467-941X Won K Cho http://orcid.org/0000-0003-0918-0565 Michael Levy http://orcid.org/0000-0002-0801-5392 John A Martin http://orcid.org/0000-0002-9499-9358 Bret T Petersen http://orcid.org/0000-0002-5635-6706 Mark Topazian http://orcid.org/0000-0003-1090-2844 Vinay Chandrasekhara http://orcid.org/0000-0001-6209-9905 Barham K Abu Dayyeh http://orcid.org/0000-0001-8084-7225
Funding Agency and Grant Number
Corresponding Author	Barham K Abu Dayyeh, MD, Associate Professor, Attending Doctor, Director, Director, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Ave., S.W., Rochester, MN 55905, United States. abudayyeh.barham@mayo.edu
Key Words	End-stage renal disease; Nationwide Inpatient Sample; Endoscopic retrograde cholangiopancreatography
Core Tip	Recognizing risk factors for endoscopic retrograde cholangiopancreatography (ERCP)-related complications is essential to reduce adverse events (AEs). There are limited data evaluating ERCP outcomes in renal disease. In a retrospective cohort study using the Nationwide Inpatient Sample 2011-2013 and including 492175 dis­charges, we compared inpatient ERCP AEs, mortality and length of stay between patients with and without renal disease. We found end-stage renal disease (ESRD) to be associated with higher post ERCP pancreatitis [8.3%, adjusted odd ratio (aOR) = 1.7, aP < 0.001], bleeding (5.1%, aOR = 1.86, aP < 0.001), mortality (7.1%, aOR = 6.6, aP < 0.001) and longer hospital stay (5.9 d, aP < 0.001). Physicians should consider special interventions in ESRD patients to decrease ERCP AEs.
Publish Date	2018-11-07 02:30
Citation	Sawas T, Bazerbachi F, Haffar S, Cho WK, Levy MJ, Martin JA, Petersen BT, Topazian MD, Chandrasekhara V, Abu Dayyeh BK. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24(41): 4691-4697
URL	http://www.wjgnet.com/1007-9327/full/v24/i41/4691.htm
DOI	http://dx.doi.org/10.3748/wjg.v24.i41.4691

Full Article (PDF)	WJG-24-4691.pdf